Man Group’s Prestige Consumer Healthcare PBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.63M | Sell |
119,056
-17,414
| -13% | -$895K | 0.01% | 1080 |
|
|
2026
Q1 | $8.09M | Sell |
136,470
-37,395
| -22% | -$2.43M | 0.01% | 906 |
|
|
2025
Q4 | $10.7M | Buy |
173,865
+64,755
| +59% | +$3.96M | 0.02% | 760 |
|
|
2025
Q3 | $6.81M | Buy |
+109,110
| New | +$7.6M | 0.01% | 956 |
|
|
2024
Q3 | – | Sell |
-4,924
| Closed | -$339K | – | 2143 |
|
|
2024
Q2 | $339K | Buy |
4,924
+21
| +0.4% | +$1.42K | ﹤0.01% | 1768 |
|
|
2024
Q1 | $356K | Sell |
4,903
-1,853
| -27% | -$124K | ﹤0.01% | 1892 |
|
|
2023
Q4 | $414K | Buy |
+6,756
| New | +$401K | ﹤0.01% | 1734 |
|
|
2023
Q3 | – | Sell |
-96,909
| Closed | -$5.86M | – | 1204 |
|
|
2023
Q2 | $5.76M | Buy |
+96,909
| New | +$5.8M | 0.02% | 819 |
|
|
2023
Q1 | – | Sell |
-142,023
| Closed | -$8.87M | – | 604 |
|
|
2022
Q4 | $8.89M | Sell |
142,023
-14,213
| -9% | -$815K | 0.03% | 621 |
|
|
2022
Q3 | $7.79M | Buy |
+156,236
| New | +$8.65M | 0.04% | 568 |
|
|
2022
Q2 | – | Sell |
-277,964
| Closed | -$15.3M | – | 401 |
|
|
2022
Q1 | $14.7M | Sell |
277,964
-46,395
| -14% | -$2.68M | 0.05% | 445 |
|
|
2021
Q4 | $19.7M | Sell |
324,359
-4,299
| -1% | -$255K | 0.06% | 376 |
|
|
2021
Q3 | $18.4M | Buy |
328,658
+11,679
| +4% | +$641K | 0.06% | 362 |
|
|
2021
Q2 | $16.5M | Buy |
316,979
+8,321
| +3% | +$400K | 0.06% | 377 |
|
|
2021
Q1 | $13.6M | Sell |
308,658
-161,473
| -34% | -$6.78M | 0.06% | 340 |
|
|
2020
Q4 | $16.4M | Sell |
470,131
-74,864
| -14% | -$2.66M | 0.07% | 270 |
|
|
2020
Q3 | $19.8M | Buy |
544,995
+131,198
| +32% | +$4.88M | 0.08% | 275 |
|
|
2020
Q2 | $15.5M | Buy |
413,797
+53,765
| +15% | +$2.15M | 0.08% | 240 |
|
|
2020
Q1 | $13.2M | Sell |
360,032
-251,965
| -41% | -$9.79M | 0.09% | 233 |
|
|
2019
Q4 | $24.8M | Buy |
611,997
+215,860
| +54% | +$8.05M | 0.08% | 287 |
|
|
2019
Q3 | $13.7M | Sell |
396,137
-35,677
| -8% | -$1.18M | 0.05% | 431 |
|
|
2019
Q2 | $13.7M | Buy |
431,814
+9,817
| +2% | +$292K | 0.05% | 492 |
|
|
2019
Q1 | $12.6M | Buy |
421,997
+34,274
| +9% | +$982K | 0.05% | 475 |
|
|
2018
Q4 | $12M | Sell |
387,723
-44,892
| -10% | -$1.64M | 0.05% | 398 |
|
|
2018
Q3 | $16.4M | Buy |
432,615
+160,876
| +59% | +$6.08M | 0.06% | 394 |
|
|
2018
Q2 | $10.4M | Buy |
271,739
+6,481
| +2% | +$218K | 0.04% | 565 |
|
|
2018
Q1 | $8.94M | Buy |
+265,258
| New | +$10.2M | 0.04% | 545 |
|
Other funds holding PBH
AI
BIP
Man Group's PBH Position: Q2 2026 in Review
Man Group reduced its Prestige Consumer Healthcare (PBH) stake by 13% in Q2 2026, selling an estimated $895K and leaving 119,056 shares worth $5.63M. The position accounts for 0.01% of the portfolio, ranked #1080.
Man Group first reported a position in PBH in Q1 2018 and has held it in 27 quarters since. The position peaked at $24.8M in Q4 2019. 320 funds tracked by Wall St. Rank hold PBH as of Q2 2026.
- Man Group held 119,056 shares of Prestige Consumer Healthcare worth $5.63M as of Q2 2026.
- Man Group sold 17,414 Prestige Consumer Healthcare shares in Q2 2026, an estimated $895K.
- Prestige Consumer Healthcare made up 0.01% of Man Group's portfolio in Q2 2026, its #1080 holding.
- Man Group first reported a position in Prestige Consumer Healthcare in Q1 2018 and has held it in 27 quarters since.
- Man Group's Prestige Consumer Healthcare position peaked at $24.8M in Q4 2019.
- 320 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.
Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.